Member Info for NoviceInvester1

Confirmed:

"Earlier today, TT held the Court Meeting and General Meeting in relation to the Scheme. The percentages of votes in favour of the resolutions at the Court Meeting and General Meeting were, in each case, below the minimum thresholds required to approve the Scheme.

As a result, Conditions 2(a)(i) and 2(b)(i) to the Scheme have not been satisfied and the Scheme and the Acquisition have lapsed.

Commenting on the results of the Meetings, Warren Tucker, Chairman of TT, said:

"The TT Board is committed to representing the interests of all of TT's shareholders and wider stakeholders and has fulfilled its duty to present the Acquisition to TT shareholders for their consideration, given its value.

As only 51.77% of shareholders by value voted in favour of the Scheme, the TT Board notes that the Acquisition will not now proceed. The result is clear and the TT Board will continue to focus on existing business delivery.

Against this background, the TT Board intends to consult with its principal shareholders on its proposed strategy to take the business forward. TT is clearly at an inflection point and accordingly, after two three-year terms as Chairman, I have informed the TT Board that I intend to step down. The TT Board has asked me to remain until the AGM in May in order to allow for an orderly transition. The TT Board will now commence the process for identifying my successor."

He won't be missed

https://www.lse.co.uk/news/TTG/berenberg-raises-target-price-on-tt-electronics-7ji5d3irk5dgzb4.html

Where is the info on the cost of the capsules? Virolens is certainly getting coverage in Australia which is great news